Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 2.098% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) O=C(c1cc2nc(-c3ccc(F)cc3)cc(C(F)(F)F)n2n1)N1CCOCC1
b.) CCC(C)C(NC=C1C(=O)OC(C)(C)OC1=O)C(=O)O
c.) Fc1ccccc1C1CCN(Cc2nc(CC3CC3)no2)C1
d.) C/C(=N\NC(=O)c1ccc(O)cc1)c1cccc(NC(=O)c2ccccc2C)c1
e.) CCCCn1c(N)c(N(CCOC)C(=O)c2cc(-c3ccccc3Cl)nc3ccccc23)c(=O)[nH]c1=O
Answer: c. Fc1ccccc1C1CCN(Cc2nc(CC3CC3)no2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Fc1ccccc1C1CCN(Cc2nc(CC3CC3)no2)C1
Fc1ccccc1C1CCN(Cc2nc(CC3CC3)no2)C1
3-(cyclopropylmethyl)-5-[[3-(2-fluorophenyl)pyrrolidin-1-yl]methyl]-1,2,4-oxadiazole